Upgrade to SI Premium - Free Trial

Allergan's (AGN) Quarter Not Strong Enough to Support Price Target - PiperJaffray

February 23, 2016 8:23 AM
Allergan (NYSE: AGN) posted a solid 4Q leading Piper Jaffray analyst, David Amsellem, to reiterate his Overweight rating but trim ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles